Literature DB >> 20803841

Transplacental transport of IgG antibodies specific for pertussis, diphtheria, tetanus, haemophilus influenzae type b, and Neisseria meningitidis serogroup C is lower in preterm compared with term infants.

Jolice P van den Berg1, Elisabeth A M Westerbeek, Guy A M Berbers, Pieter G M van Gageldonk, Fiona R M van der Klis, Ruurd M van Elburg.   

Abstract

BACKGROUND: Maternal antibodies, transported through the placenta during pregnancy, contribute to the protection of infants from infectious diseases during the first months of life. The aim of this study was to measure the concentration of antibodies against several vaccine-preventable diseases in paired maternal and cord blood serum samples in preterm and term infants and to assess placental transfer ratios and infant antibody concentrations against vaccine-preventable diseases.
METHODS: Antibody concentrations specific against pertussis proteins (pertussis toxin, filamentous hemagglutinin, pertactin, and fimbriae), diphtheria and tetanus toxins, and antibody concentrations specific against polysaccharides from Haemophilus influenzae type b and Neisseria meningitidis serogroup C were measured in cord blood samples from preterm (<32 weeks and 1500 g) and term infants and maternal serum samples, using a fluorescent bead-based multiplex immunoassay.
RESULTS: A total of 96 preterm and 42 term infants and their mothers were included in the study. Placental transfer ratios of antibodies against all vaccine antigens were significantly lower in preterm infants (medians varied from 0.26 to 0.86) compared with term infants (medians, 0.74-1.89; all antibodies P < 0.05). Furthermore, polysaccharide-vaccine-specific antibodies showed lower transplacental transport ratios than protein-vaccine-specific antibodies. Maternal concentrations are the most important determinants of infant antibody concentrations against vaccine-preventable diseases.
CONCLUSIONS: Preterm infants benefit to a lesser extent from maternal antibodies against vaccine-preventable diseases than term infants, posing them at higher risk for infectious diseases in the first months of life.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20803841     DOI: 10.1097/inf.0b013e3181dc4f77

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  39 in total

1.  Decline of antibodies in XLA infant: when to start IVIG.

Authors:  I U Okocha; C G Hanson; J Chinen; W T Shearer
Journal:  Allergy       Date:  2010-09-07       Impact factor: 13.146

2.  Decline of IgG pertussis toxin measured in umbilical cord blood, and neonatal and early infant serum.

Authors:  L C S Smallenburg; N A van Welie; L H Elvers; J C M van Huisseling; P F M Teunis; F G A Versteegh
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-04-23       Impact factor: 3.267

3.  The National Vaccine Advisory Committee: reducing patient and provider barriers to maternal immunizations: approved by the National Vaccine Advisory Committee on June 11, 2014.

Authors: 
Journal:  Public Health Rep       Date:  2015 Jan-Feb       Impact factor: 2.792

4.  Plasma cell and serum antibody responses to influenza vaccine in preterm and full-term infants.

Authors:  Carl T D'Angio; Claire P Wyman; Ravi S Misra; Jessica L Halliley; Hongyue Wang; Julianne E Hunn; Caitlin M Fallone; F Eun-Hyung Lee
Journal:  Vaccine       Date:  2017-08-12       Impact factor: 3.641

Review 5.  Antenatal immunization.

Authors:  Chrissie Jones; Paul Heath
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

6.  Association of Routine Infant Vaccinations With Antibody Levels Among Preterm Infants.

Authors:  Elsbeth D M Rouers; Patricia C J Bruijning-Verhagen; Pieter G M van Gageldonk; Josephine A P van Dongen; Elisabeth A M Sanders; Guy A M Berbers
Journal:  JAMA       Date:  2020-09-15       Impact factor: 56.272

7.  Tetanus and diphtheria immunity among term and preterm infant-mother pairs in Turkey, a country where maternal and neonatal tetanus have recently been eliminated.

Authors:  Tugba Erener-Ercan; Mustafa Aslan; Mehmet Vural; Ethem Erginoz; Bekir Kocazeybek; Gokmen Ercan; Lale Wetherilt Turkgeldi; Yildiz Perk
Journal:  Eur J Pediatr       Date:  2014-08-30       Impact factor: 3.183

Review 8.  Immunization of pregnant women: Future of early infant protection.

Authors:  Azure N Faucette; Michael D Pawlitz; Bo Pei; Fayi Yao; Kang Chen
Journal:  Hum Vaccin Immunother       Date:  2015-09-14       Impact factor: 3.452

Review 9.  The developing human preterm neonatal immune system: a case for more research in this area.

Authors:  Ashish Arunkumar Sharma; Roger Jen; Alison Butler; Pascal M Lavoie
Journal:  Clin Immunol       Date:  2012-08-17       Impact factor: 3.969

Review 10.  Maternal vaccination: moving the science forward.

Authors:  Azure N Faucette; Benjamin L Unger; Bernard Gonik; Kang Chen
Journal:  Hum Reprod Update       Date:  2014-07-11       Impact factor: 15.610

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.